Facebook
Twitter
LinkedIn
Forward
2023 Cytopathology Crash Course
The Cytopathology Crash Course provides a high-yield review of cytopathology morphology and concepts for trainees, as well as a refresher course on core cytopathology concepts for practitioners. This online course is designed for pathology residents, cytopathology fellows, junior cytologists, practicing pathologists and cytologists; experienced pathologists seeking a review of cytopathology concepts.
You must register by clicking the button below. Once your registration is complete you will receive the access code.
Target Audience
This online course is designed for pathology residents, cytopathology fellows, junior cytologists, practicing pathologists and cytologists; experienced pathologists seeking a review of cytopathology concepts.
Learning Objectives
- Recognize the classic cytomorphologic features associated with certain diagnostic entities
- Describe the molecular tests that are often performed on cytopathology specimens
- Understand common methods used to prepare cytopathology specimens
- List and explain the major regulations that apply to cytopathology laboratories
Course Faculty
| Ayesha Baig, MD, MSc,FRCPC | Christine N. Booth, MD | Bonnie Choy, MD |
| Kelly Ernst, MD | Nadja Falk, MD | Peter B. Illei, MD |
| Vicki Y. Jo, MD | Sigfred Lajara, MD | Seyedreza Mousavi, MD, MS, CT(ASCP) |
| Michiya Nishino, MD, PhD | Christopher J. O'Conor, MD, PhD | Chelsea Peeler, MCP, HTL(ASCP)CM, CTCM |
| M. Katayoon Rezaei, MD | Frida Rosenblum, MD | Kaitlin Sundling, MD, PhD |
| Michael J. Thrall, MD | Vanda F. Torous, MD | Christopher J. VandenBussche, MD, PhD |
| Rebecca Yoda, MD | Sara Zadeh, MD | M. Lisa Zhang, MD |
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.
The following individuals have reported financial relationships:
Peter B. Illei, MD: Advisor/Consultant - AstraZeneca, Sanofi/Genzyme, Consultant - Genentech, Advisior - Roche, Janssen, Merus Corp, Speaker - Eli Lilly, Sponsored research - Erbe Medical Systems, Advisor/Sponsored research - Bristol Myers Squib
Vickie Jo, MD: Stock - Merck and Co
Oscar Lin, MD, PhD: Consultant – Hologic and Jansen
Liron Pantanowitz, MD: Consultant – Hamamatsu, Advisory Board for Ibex
Martha B Pitman, MD, FIAC: Consultant – Adenocyte, LLC
Donna K. Russell, Med, CT(ASCP), HT(ASCP): Advisory Board – Hologic Scientific
Christopher J. VandenBussche, MD, PhD: Advisory board Member – AlxMED
The following individuals have reported no relevant financial relationships:
Susan A. Alperstein, MS, CT(ASCP), Kristen A. Atkins, MD, Christine N. Booth, MD, Barbara A. Centeno, MD, Deborah J. Chute, MD, Amy C. Clayton, MD, Jacqueline M. Cuda, BS, SCT(ASCP), Sean A. McNair, MPH, CT(ASCP), Michelle D. Reid, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin T. Siddiqui, MD, FIAC, Michael J. Thrall, MD, Christopher J. O’Conor, MD, PhD, Seyedreza Mousavi, MD, MS, CT(ASCP), Chelsea Peeler, MCP, HTL(ASCP)CM, CTCM, Kaitlin Sundling, MD, PhD, Bonnie Choy, MD, Sara Zadeh, MD, Michiya Nishino, MD, PhD, Kelly Ernst, MD, M. Katayoon Rezaei, MD, Rebecca Yoda, MD, M. Lisa Zhang, MD, Frida Rosenblum, MD, Nadja Falk, MD, Sigfred Lajara, MD, Ayesha Baig, MD, MSc, FRCPC, Vanda F. Torous, MD, Jimmie Stewart, MD
The ASC staff associated with the development of content for this activity reported no relevant financial relationships.
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Continuing Certification (CC)
This product can help fulfill the CME requirements mandated by the American Board of Pathology Continuing Certification (CC) process. Earn up to 10.0 Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 10.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
Available Credit
- 10.00 AMA PRA Category 1 Credit™
- 10.00 California Credits
- 10.00 CMLE
- 10.00 Florida Credits
- 10.00 Participant